Lista de obras - Li C Cheung - Dominio Público Uruguay

A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screening

artículo científico publicado en 2015

Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection

artículo científico publicado en 2014

Basing eligibility for lung cancer screening on individualized risk calculators should save more lives, but life-expectancy matters

artículo científico publicado en 2019

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines ⬇️

artículo científico publicado el 1 de abril de 2013

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

artículo científico publicado en 2011

Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21-39 years

artículo científico publicado en 2018

Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage

artículo científico publicado en 2020

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening

artículo científico publicado en 2016

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years ⬇️

artículo científico publicado el 1 de abril de 2013

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results ⬇️

artículo científico publicado el 1 de abril de 2013

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results ⬇️

artículo científico publicado el 1 de abril de 2013

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results ⬇️

artículo científico publicado el 1 de abril de 2013

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive ⬇️

artículo científico publicado el 1 de abril de 2013

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

artículo científico publicado en 2010

Long‐term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment ⬇️

artículo científico publicado el 30 de agosto de 2011

Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.

artículo científico publicado en 2012

Prioritized concordance index for hierarchical survival outcomes

scientific article published on 07 April 2019

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test

artículo científico publicado en 2014

Response

artículo científico publicado en 2014

Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.

artículo científico publicado en 2015

Risk of Cervical Precancer and Cancer Among Uninsured and Underserved Women 2009-2017

artículo científico publicado en 2020

Risk of cataract after exposure to low doses of ionizing radiation: a 20-year prospective cohort study among US radiologic technologists

artículo científico publicado en 2008

Risk-Based Selection of Individuals for Oral Cancer Screening

artículo científico publicado en 2021

Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines

artículo científico publicado en 2016

The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management.

artículo científico publicado en 2014

Using Prediction-Models to Reduce Persistent Racial/Ethnic Disparities in Draft 2020 USPSTF Lung-Cancer Screening Guidelines

artículo científico publicado en 2021

Lista de obras de Li C Cheung

A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screening

Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection

Basing eligibility for lung cancer screening on individualized risk calculators should save more lives, but life-expectancy matters

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines ⬇️

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21-39 years

Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years ⬇️

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results ⬇️

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results ⬇️

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results ⬇️

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive ⬇️

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

Long‐term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment ⬇️

Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.

Prioritized concordance index for hierarchical survival outcomes

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test

Response

Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.

Risk of Cervical Precancer and Cancer Among Uninsured and Underserved Women 2009-2017

Risk of cataract after exposure to low doses of ionizing radiation: a 20-year prospective cohort study among US radiologic technologists

Risk-Based Selection of Individuals for Oral Cancer Screening

Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines

The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management.

Using Prediction-Models to Reduce Persistent Racial/Ethnic Disparities in Draft 2020 USPSTF Lung-Cancer Screening Guidelines